A New Dawn: Canadian Exodus & Alternative Capital

With COMPASS Pathways' listing and early success on NASDAQ, a clear precedent is set. The premise of psychedelic medicine has been accepted by more extensive and more scrupulous investors and institutions.

The Canadian Exodus

Last Monday, three days after COMPASS’s IPO, MindMed promptly announced plans to up-list to the NASDAQ.

"Mind Medicine... is evaluat…

This post is for paying subscribers